Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission

Pediatric Infectious Disease Journal

Volumn 27, Issue 1, 2008, Pages 22-26

  Creek, Tracy ^a   Tanuri, Amilcar ^a   Smith, Monica ^a   Seipone, Khumo ^b   Smit, Molly ^a   Legwaila, Keitumetse ^a   Motswere, Catherine ^a   Maruping, Maruping ^a   Nkoane, Tapologo ^a   Ntumy, Ralph ^a   Bile, Ebi ^a   Mine, Madisa ^b   Lu, Lydia ^a   Tebele, Goitebetswe ^a   Mazhani, Loeto ^b   Davis, Margarett K ^a   Roels, Thierry H ^a   Kilmarx, Peter H ^a   Shaffer, Nathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Department of HIV AIDS Prevention and Care   (Botswana)

Author keywords

Botswana; Dried blood spot; HIV; HIV testing; Infant HIV diagnosis; PCR; Prevention of mother to child transmission; Program effectiveness; Vertical transmission

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

ARTICLE; BLOOD SAMPLING; BOTSWANA; DRIED BLOOD SPOT; EARLY DIAGNOSIS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; INFANT DISEASE; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NATIONAL HEALTH SERVICE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 37549041351     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181469050     Document Type: Article

References (24)

1. Botswana Ministry of Health. 2005 HIV/AIDS Surveillance Technical Report. Gaborone: Botswana Ministry of Health, 2005.
2. Wiktor SZ, Ekpini E, Nduati RW. Prevention of mother-to-child transmission of HIV-1 in Africa. AIDS. 1997;11(suppl B):S79-S87.
3. Nolan ML, Greenberg AE, Fowler MG. A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS. 2002;16:1991-1999.
4. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
5. Government of Botswana Central Statistics Office. 1992-2002 Health Statistics Report. Gaborone: Central Statistics Office; 2003.
6. Botswana National Antiretroviral Program. Masa Patient Enrollment Update: June 2006. Gaborone: Botswana National Antiretroviral Program; 2006.
7. Anabwani G, Jimbo W. Botswana Guidelines on Antiretroviral Therapy. Botswana Ministry of Health; 2005.
8. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9: F7-F11.
9. Rollins NC, Dedicoat M, Danaviah S, et al. Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet. 2002;360:389.
10. Sherman GG, Jones SA, Coovadia AH, Urban MF, Bolton KD. PMTCT from research to reality - results from a routine service. S Afr Med J. 2004;94:289-292.
11. Sherman GG, Cooper PA, Coovadia AH, et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993-997.
12. Government of Botswana Central Statistics Office 2001. Population and Housing Census. Gaborone: Central Statistics Office; 2001.
13. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171-1177.
14. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.
15. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773-780.
16. Shapiro RL, Thior I, Gilbert PB, et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS. 2006;20:1281-1288.
17. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19:309-318.
18. Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/ newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288:189-198.
19. Varga CA, Sherman GG, Maphosa J, Jones SA. Psychosocial consequences of early diagnosis of HIV status in vertically exposed infants in Johannesburg, South Africa. Health Care Women Int. 2005;26:387-397.
20. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
21. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA. 2005;293:2221-2231.
22. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr. 2005;38:615-617.
23. Fischer A, Lejczak C, Lambert C, et al. Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol. 2004;42:16-20.
24. Sherman GG, Matsebula TC, Jones SA. Is early HIV testing of infants in poorly resourced prevention of mother to child transmission programmes unaffordable? Trop Med Int Health. 2005;10: 1108-1113.